November 26, 2024
UNC Lineberger members recognized for highly cited research
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to an independent analysis of research publications.
Tag: Katherine Hoadley
November 30, 2023
Hoadley gets a special ride during Carolina Hurricanes’ Hockey Fights Cancer game
UNC Lineberger's Katie Hoadley, PhD, rode on the Zamboni during the Carolina Hurricanes’ Hockey Fights Cancer game.
November 16, 2023
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
May 10, 2023
Leading investigators offer ‘highly scientific, but patient-focused’ talks on women’s cancers at symposium
UNC Lineberger’s 46th annual Scientific Symposium brought together more than 350 people in person and virtually to hear talks on the latest research on women’s cancers.
January 9, 2023
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
January 5, 2023
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
November 18, 2022
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
November 14, 2022
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
October 3, 2022
UNC Lineberger pancreatic cancer therapy studies backed by 5-year, $10.9 million NIH SPORE grant
The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.
April 12, 2022
AURORA study identifies molecular features tied to breast cancer tumor spread
UNC Lineberger’s Susana Garcia-Recio, PhD, and colleagues have identified molecular features responsible for the development and progression of metastatic breast cancer.